spacer
home > > autumn 2009 > integral values
PUBLICATIONS


Integral Values

There has been of lot of buzz around the integration of clinical research (especially electronic data capture (EDC)) with healthcare (electronic health records (EHRs) in particular) over the last few months. Therefore, it is a good time to review the current status, to discuss what the major hurdles for real-life implementation are, and to look at the regulatory issues, especially regarding submissions to the FDA.

CURRENT STATUS

Clinical investigators don’t have an easy life. They often need to enter the same data twice, once in the hospital information system (HIS) and then again in the clinical EDC system. Often, this also means that they need to work with different computers, one for the HIS and one for the EDC system. In the best case scenario, they can copy and paste information from one application into the other.

Ideally, hospital information systems should keep, or be able to produce, EHRs of the patients that are being treated. These can then be used later by other caretakers in other hospitals or by the patient’s own general practicioner. Many countries in the world currently have programmes to develop standardised EHRs, but unfortunately, each country has its own strategy and technical requirements, resulting in a multitude of formats and systems. This is especially a problem in Europe, where more and more people use their right to free movement of labour, and move to another country regularly (1).

With the rise of EHRs, a number of projects surrounding the integration of EDC and EHRs have seen the light in the last few years. Almost all of them have been initiated by Landen Bain, CDISC’s ‘liason to healthcare’. The first results are now being demonstrated and the first real-life system has now gone into production (2).

The earliest, and best known project is still the IHE RFD profile (3). IHE stands for ‘integrating the healthcare industry’ and is an initiative of healthcare IT professionals, mostly from vendor companies; clinical research is only a small part of the initiative. IHE publishes so-called ‘profiles’ which can be seen as a project description. One of these is the ‘retrieve for data capture’ (RFD) profile. It describes the criteria and proposes technologies for the retrieval of information from an EHR to prefill an electronic case report form (eCRF) with data from the EHR. The profile only describes ‘how it can be done’. For example, the original RFD profile assumed XForms technology for the EDC system, but in real life, this will of course not always be the case.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Jozef Aerts is CEO of XML4Pharma, a consultancy and software development company specialising in XML technologies for the pharma industry. Jozef is one of the lead developers of the CDISC ODM standard, and also contributes to other CDISC standards. He is also involved in CDISC’s efforts to integrate clinical research with healthcare.
spacer
Jozef Aerts
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma and Memo Therapeutics AG collaborate on the fast-track manufacturing of a SARS-CoV-2- neutralizing antibody for the therapy of COVID-19

Vilnius, Lithuania, and Schlieren, Switzerland – August 11, 2020 – Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Swiss biotech company Memo Therapeutics AG (MTx), announce a new partnership to manufacture MTx’s therapeutic COVID-19 antibody candidate in a 4-month fast-track process approved by regulatory authorities.
More info >>

White Papers

Mauritius Island – An Emerging Centre for R&D in Biotechnology and the Life Sciences

CIDP (Centre International de Développement Pharmaceutique)

Mauritius, the tropical island situated in the Indian Ocean and known worldwide for its beautiful beaches, is also internationally recognised for its rule of law, and political and social stability. Over the past few years, the economy has been successfully transitioned from a monocrop to a diversified innovation-driven and knowledge-based economy, resting on agribusiness, export-oriented manufacturing, tourism, financial services, property development and real estate, ICT-BPO, the seafood industry, a free port, logistics and a nascent ocean economy. Emerging sectors such as healthcare and life sciences are presenting some niche areas for the taking, and the enabling environment is being put in place to make it happen - especially in the light of sustained growth within pharmaceutical, medical device, and clinical research. Important international players are already in operation locally as the country has established the appropriate legal and regulatory frameworks based on international norms, for the development of a strong biomedical research sector.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement